02/10/2015
https://www.congress.gov...
"Okay. Let us move on to the price increase on Isuprel and Nitropress."
"if you make an acquisition of some older products, in a way the only rationale for making that acquisition is to raise prices to earn a return"
"If it walks like a duck and talks like a duck, it is lobbying."
"I think it is misleading to act as if this is a problem with four drugs. This is the business model."